Notes
Journal of Natural Products, 2009, Vol. 72, No. 1 175
Cyanopeptolin 880 (1): white powder; [R]D -38 (c 0.07, MeOH);
UV (MeOH) λmax (log ε) 279 (2.95) nm; IR (film) νmax 3435, 1645,
1456, 1384 cm-1; 1H NMR (500 MHz, MeOH-d3) δ Ahp: 7.69 (1H, d,
J ) 9.0 Hz, N-H), 6.34 (1H, brd, O-H), 5.04 (1H, d, J ) 1.7 Hz, H-5),
4.56 (1H, m, H-2), 2.78 (1H, m, H-3a), 1.88 (3H, m, H-3b, H-4); Hty:
8.41 (1H, d, J ) 7.5 Hz, N-H), 6.97 (2H, d, J ) 8.5 Hz, H-2′, H-6′),
6.66 (2H, d, J ) 8.5 Hz, H-3′, H-5′), 4.32 (1H, m, H-2), 2.66 (1H, m,
H-4a), 2.51 (1H, m, H-4b), 2.51 (1H, m, H-3a), 1.88 (1H, m, H-3b);
Ile-1: 4.50 (1H, d, J ) 10.7 Hz, H-2), 1.88 (1H, m, H-3), 1.12 (1H, m,
H-4a), 0.70 (1H, m, H-4b), 0.66 (3H, dd, J ) 6.8, 5.0 Hz, H-5), -0.13
(3H, d, J ) 6.5 Hz, H-3′); Ile-2: 8.13 (1H, d, J ) 9.0 Hz, N-H), 4.42
(1H, t, J ) 8.6 Hz, H-2), 1.88 (1H, m, H-3), 1.45 (1H, m, H-4a), 1.21
(1H, m, H-4b), 0.96 (3H, d, J ) 6.9 Hz, H-3′), 0.88 (3H, t, J ) 7.4
Hz, H-5); N-Me-Phe: 7.29 (2H, d, J ) 7.4 Hz, H-2, H-6), 7.24 (2H, t,
J ) 7.4 Hz, H-3, H-5), 7.16 (1H, t, J ) 7.4 Hz, H-4), 5.24 (1H, dd, J
) 11.6, 2.8 Hz, H-2), 3.52 (1H, dd, J ) -14.5, 2.8 Hz, H-3a), 2.83
(3H, s, N-Me), 2.80 (1H, dd, J) -14.5, 11.6 Hz, H-3b); Thr: 8.08
(1H, d, J ) 9.0 Hz, N-H), 5.60 (1H, q, J ) 6.6 Hz, H-3), 4.83 (1H, d,
J ) 9.0 Hz, H-2), 1.39 (3H, d, J ) 6.6 Hz, H-4); 2-OMe-GA: 3.96
(1H, dd, J ) 6.0, 3.7 Hz, H-2), 3.85 (1H, dd, J ) -11.7, 3.7 Hz,
H-3a), 3.77 (1H, dd, J ) -11.7, 6.0 Hz, H-3b), 3.54 (3H, s, O-Me);
13C NMR (125 MHz, MeOH-d3) δ Ahp: 171.1, 76.2, 51.2, 31.4, 22.3;
Hty: 174.3, 156.8, 132.8, 130.6, 116.3, 54.8, 33.7, 32.1; Ile-1: 172.8,
56.6, 34.6, 25.1, 15.0, 10.8; Ile-2: 175.5, 58.2, 38.0, 26.6, 16.2, 10.2;
N-Me-Phe: 172.0, 139.0, 130.9, 130.0, 128.0, 63.0, 35.4, 31.5; Thr:
171.3, 73.4, 56.8, 18.9; 2-OMe-GA: 173.9, 84.5, 63.9, 58.9; HRES-
ITOFMS m/z [M + H]+ 881.4645 (calcd for C45H65N6O12, 881.4660,
1.5 ppm error).
cyanopeptolin 880 (1) was not observed when the strain was grown
in nonsupplemented medium. This observation may mean that
sulfation is rate limiting and that supplementation with homotyrosine
results in a higher flux through the early part of the pathway.
However, this observation was not pursued further.
Members of the cyanopeptolin8 and anabaenopeptin16 classes
of compounds are known protease inhibitors. We did not observe
trypsin/chymotrypsin inhibition by either 3 or 4 at concentrations
up to 100 µg/mL. However, in a standard assay 4 inhibited
carboxypeptidase A with an IC50 of 0.12 µg/mL, while 3 was
inactive at concentrations up to 20 µg/mL, the highest concentration
tested.
The present investigation was concerned with the peptide
metabolite spectrum of strain CYA126/8 as a foundation on which
a better understanding of peptide biosynthesis in cyanobacteria may
be built. Last, it should be noted that 3 and 4 are obviously products
of the NRPS pathway. Our current understanding of NRPS
biochemistry cannot readily explain the co-occurrence of two closely
related metabolites bearing two quite different amino acids, such
as arginine and tyrosine in equivalent positions.
Experimental Section
General Experimental Procedures. Optical rotation data were
recorded on a JASCO DIP-700 polarimeter. IR and UV spectra were
recorded using a Thermo Nicolet Avatar 380 and a Beckman DU-7000
spectrometer, respectively. Nuclear magnetic resonance (NMR) spectra
were recorded using Shigemi tubes on a Varian UNITY INOVA 500
instrument equipped with a 3 mm microprobe. Chemical shifts are
referenced to residual protiated solvent. High-performance liquid
chromatography (HPLC) was performed on a Shimadzu AS-10VP
gradient system using either a 5 µm Lichrospher ODS column (4.6 ×
250 mm) or a 5 µm Phenomenex Luna C-18(2) column (4.6 × 250
mm or 10 × 250 mm). HRESITOFMS spectra were recorded in the
flow injection mode on an Agilent 6100 LC-MSDTOF system equipped
with an Agilent 1100 LC module. HRFABMS data were recorded on
a VG ZAB-70 instrument using a glycerol matrix.
Cyanopeptolin 960 (2): white powder; [R]D -39 (c 0.05, MeOH);
UV (MeOH) λmax (log ε) 279 (2.94) nm; IR (film) νmax 3440, 1645,
1
1455, 1361, 1206 cm-1; H NMR (500 MHz, MeOH-d3) δ Ahp: 7.69
(1H, d, J ) 9.0 Hz, N-H), 6.34 (1H, brd, O-H), 5.04 (1H, d, J ) 5.4
Hz, H-5), 4.56 (1H, m, H-2), 2.78 (1H, m, H-3a), 1.88 (3H, m, H-3b,
H-4); Hty: 8.41 (1H, d, J ) 7.5 Hz, N-H), 6.97 (2H, d, J ) 8.5 Hz,
H-2′, H-6′), 6.66 (2H, d, J ) 8.5 Hz, H-3′, H-5′), 4.32 (1H, m, H-2),
2.66 (1H, m, H-4a), 2.51 (1H, m, H-4b), 2.38 (1H, m, H-2a), 1.88
(1H, m, H-2b); Ile-1: 4.50 (1H, d, J ) 10.7 Hz, H-2), 1.88 (1H, m,
H-3), 1.12 (1H, m, H-4), 0.70 (1H, m, H-4), 0.66 (3H, dd, J ) 6.8, 5.0
Hz, H-5), -0.13 (3H, d, J ) 6.5 Hz, H-3′); Ile-2: 8.13 (1H, d, J ) 9.0
Hz, N-H), 4.42 (1H, dd, J ) 8.6, 8.6 Hz, H-2), 1.88 (1H, m, H-3),
1.45(1H, m, H-4a), 1.21 (1H, m, H-4b), 0.96 (3H, d, J ) 6.9 Hz, H-3′),
0.88 (3H, t, J ) 7.4 Hz, H-5); N-Me-Phe: 7.29 (2H, m, H-2′, H-6′),
7.24 (2H, m, H-3′, H-5′), 7.16 (1H, m, H-4′), 5.24 (1H, dd, J ) 11.6,
2.8 Hz, H-2), 3.52 (1H, dd, J ) -14.5, 2.8 Hz, H-3a), 2.80 (1H, dd,
J) -14.5, 11.6 Hz, H-3b); 2-OMe-GA sulfate: 4.49 (1H, dd, J ) 4.7,
2.7 Hz, H-2), 4.35 (1H, dd, J) -10.4, 2.7 Hz, H-3a), 4.28 (1H, dd, J
) -10.4, 4.7 Hz, H-3b), 3.54 (3H, s, O-Me); Thr: 8.08 (1H, d, J )
7.5 Hz, N-H), 5.60 (1H, q, J ) 6.6 Hz, H-3), 1.39 (3H, d, J ) 6.6 Hz,
H-4); 13C NMR (125 MHz, MeOH-d3) δ Ahp: 171.1, 76.2, 51.2, 31.4,
22.3; Hty: 174.3, 156.8, 132.8, 130.6, 116.3, 54.8, 33.7, 32.1; Ile-1:
172.8, 56.6, 34.6, 25.1, 15.0, 10.8; Ile-2: 175.5, 58.2, 38.0, 26.6, 16.2,
10.6; N-Me-Phe: 172.0, 139.0, 130.9, 130.0, 128.0, 63.0, 35.4, 31.5;
2-OMe-GA sulfate: 173.9, 84.5, 63.9, 58.9; Thr: 171.3, 73.4, 56.8, 18.9;
HRESITOFMS m/z [M + H]+ 961.4223 (calcd for C45H65N6O15S,
961.4229, 0.6 ppm error).
Biological Material. Planktothrix agardhii. CYA126/8 was a kind
gift of Kaarina Sivonen (University of Helsinki). This strain is deposited
in the Norwegian Institute of Water Research culture collection and is
maintained in the culture collection in the Chemistry Department at
the University of Hawaii. Cultures were grown in 20 L carboys in Z+G
medium.18 Continuous illumination was by soft white fluorescent lights
at 100 µE s-1
.
Isolation of Peptides. Cultures were concentrated by low-pressure
filtration over ultrafiltration membranes. The concentrated cell suspen-
sion was pelleted by centrifugation to yield 7.4 g of cell paste. The
pellet was freeze-dried (1.6 g dry wt), suspended in 50% MeOH(aq)
(10 mL/g dry weight), sonicated, and extracted twice with vigorous
shaking for 30 min. The combined extracts were evaporated and applied
to a YMC-ODS-A flash column (4.0 g) equilibrated in 30% aqueous
MeOH. The column was washed with additional 30% MeOH(aq) and
then eluted with a step gradient of MeOH in H2O (30 mL/step).
Compounds 1, 2, and 3 eluted in the 70% fraction, whereas compound
4 eluted in the 50% fraction. Further purification was achieved by
reversed-phase HPLC (Luna C-18(2), 10 × 250 mm, 3 mL/min)
employing a gradient of CH3CN(aq) containing 0.05% TFA (30%
CH3CN(aq) from 0-10 min, to 50% CH3CN(aq) over 15 min, 50%
CH3CN(aq) for 5 min, and to 100% CH3CN in 5 min). Compound 3
elutes after 8.6 min (4.9 mg), compound 4 after 21.5 min (3.9 mg),
and compounds 1 and 2 as a mixture of anomers after 24.4 min. The
cyanopeptolins are resolved by HPLC on a Lichrosphere C-18 column
(4.6 × 250 mm, 1 mL/min) with a gradient starting at 45% CH3CN(aq)
ramping to 50% CH3CN(aq) in 20 min and holding for 5 min.
Cyanopeptolin (1) (1.5 mg) elutes after 9.5 min (anomer (1.4 mg) at
15.1 min), cyanopeptolin (2) (0.5 mg) after 3.4 min, and its anomer
(0.8 mg) after 4.5 min, respectively.
Anabaenopeptin 908 (3): [R]D -29 (c 0.05, MeOH); UV (MeOH)
1
λmax (log ε) 280 (3.39) nm; IR (film) νmax 1652 cm-1; H NMR and
13C NMR, see Table 1; HRESITOFMS m/z [M + H]+ 909.5198 (calcd
for C45H69N10O10, 909.5204, 0.7 ppm error).
Anabaenopeptin 915 (4): white powder; [R]D -21 (c 0.05, MeOH);
UV (MeOH) λmax (log ε) 280 (3.46) nm; IR (film) νmax 1652 cm-1; 1H
NMR (500 MHz, MeOH-d3) δ Ile: 8.42 (1H, d, J ) 9.6 Hz, N-H),
4.30 (1H, dd, J ) 9.6, 6.2 Hz, H-2), 2.03 (1H, m, H-3), 1.38 (1H, m,
H-4a), 1.10 (1H, m, H-4b), 0.85 (3H, d, J ) 6.9 Hz, H-3′), 0.79 (3H,
t, J ) 7.4 Hz, H-5); N-Me-Hty: 6.97 (2H, d, J ) 8.5 Hz, H-2′, H-6′),
6.68 (2H, d, J ) 8.5 Hz, H-3′, H-5′), 4.52 (1H, dd, J ) 6.5, 7.2 Hz,
H-2), 2.70 (3H, s, N-Me), 2.32 (1H, dt, J ) -12.4, 5.0 Hz, H-4a),
2.26 (1H, dt, J ) -12.4, 4.6 Hz, H-4b), 2.12 (1H, m, H-3a), 1.80 (1H,
m, H-3b); Hty: 8.96 (1H, d, J ) 4.7 Hz, N-H), 7.06 (2H, d, J ) 8.3
Hz, H-2′, H-6′), 6.68 (2H, d, J ) 8.3 Hz, H-3′, H-5′), 4.66 (1H, m,
H-2), 2.78 (1H, m, H-4a), 2.64 (1H, m, H-4b), 2.12 (1H, m, H-3a),
1.80 (1H, m, H-3b); Val: 7.28 (1H, d, J ) 4.7 Hz, N-H), 3.92 (1H, dd,
J ) 8.0, 5.9 Hz, H-2), 1.97 (1H, m, H-3), 0.98 (6H, d, J ) 6.8 Hz,
H-4, H-4′); Lys: 7.31 (1H, dd, J ) 7.0, 3.0 Hz, N-Hε), 6.64 (1H, d, J
) 4.7 Hz, N-H), 4.06 (1H, m, H-2), 3.54 (2H, m, H-6), 1.91 (1H, m,
Feeding Experiment. DL-Homotyrosine (100 mg) was suspended
in 14 mL of distilled water, and the minimum amount of diluted HCl
was added to effect dissolution. The resulting solution was dispensed
through a sterile filter in equal 1 mL portions every day over two weeks
starting 10 days after inoculation. Fermentation was continued for
another 10 days after the last addition of compound.